Programmable Nanomedicine and Multifunctional Vectors for the Selective Targeting of HIV-1 Reservoirs: Toward a Next-Generation Shock & Kill Strategy

The persistence of latent,replication-competent HIV-1 reservoirs remains the definitive barrier to a cure. This conceptual review argues for a paradigm shift from systemic drug delivery to precision-guided intervention, enabled by programmable nanomedicine. We critically examine the design and function of multifunctional nanovectors engineered to execute the complete "Shock & Kill" sequence—targeted latency reversal, immune engagement, and specific elimination of reactivated cells—within a single, spatiotemporally controlled system. By integrating stimuli-responsive materials, combinatorial drug payloads, and surface targeting ligands, these platforms directly address the core limitations of conventional approaches: poor reservoir penetration, lack of specificity, and toxic off-target effects. This work synthesizes a roadmap for translating nanomedicine from a promising technological framework into an orchestrated therapeutic reality capable of dismantling viral persistence.